Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ronalds Mačuks
Observed names:
Mačuks, Ronalds,
R Macuks,
R. Macuks,
R. Mačuks,
Ronalds Macuks
Institutions:
Pauls Stradiņš Clinical University Hospital,
Riga Stradiņš University
Observed institutions:
Complejo Hospitalario Universitario de Santiago,
Riga East University Hospital,
Pauls Stradiņš Clinical University Hospital,
Riga Stradiņš University,
Latvian Academy of Sciences
ORCID:
0000-0001-6653-955X
Observed ORCID:
0000-0001-6653-955X
OpenAlex ID:
A5068080107
Prognostic factors in patients with vulvar cancer: the VULCAN study
2020
·
Ignacio Zapardiel
, Sara Iacoponi
, et al.
·
International Journal of Gynecological Cancer
·
80
The future for follow-up of gynaecological cancer in Europe. Summary of available data and overview of ongoing trials
2017
·
S.C. Leeson
, K. Beaver
, et al.
·
European Journal of Obstetrics & Gynecology and Reproductive Biology
·
32
An ovarian cancer malignancy risk index composed of HE4, CA125, ultrasonographic score, and menopausal status: use in differentiation of ovarian cancers and benign lesions
2012
·
Ronalds Macuks
, Ieva Baidekalna
, et al.
·
Tumor Biology
·
32
Prognostic factors in patients with uterine sarcoma: the SARCUT study
2023
·
Ignacio Zapardiel
, Myriam Gracia Segovia
, et al.
·
International Journal of Gynecological Cancer
·
29
Prognostic value of lymph node ratio and number of positive inguinal nodes in patients with vulvar cancer
2017
·
Stephan Polterauer
, Richard Schwameis
, et al.
·
Gynecologic Oncology
·
28
Gynecologic Oncology Training Systems in Europe
2011
·
Murat Gultekin
, Polat Dursun
, et al.
·
International Journal of Gynecological Cancer
·
25
Urinary Concentrations of Human Epidydimis Secretory Protein 4 (He4) in The Diagnosis of Ovarian Cancer: A Case-Control Study
2012
·
Ronalds Macuks
, Ieva Baidekalna
, et al.
·
Asian Pacific Journal of Cancer Prevention
·
20
PDF
Utility Serum Marker HE4 for the Differential Diagnosis Between Endometriosis and Adnexal Malignancy
2015
·
Ignacio Zapardiel
, Mikel Gorostidi
, et al.
·
International Journal of Gynecological Cancer
·
14
Utility of human epididymis protein 4 serum marker for the detection of adnexal malignancy: a multicentric prospective study
2016
·
Ignacio Zapardiel
, Mikel Gorostidi
, et al.
·
European Journal of Cancer Prevention
·
13
Midline Involvement as a Risk Factor for Vulvar Cancer Recurrence
2012
·
Jekaterina Stankevica
, Ronalds Macuks
, et al.
·
Asian Pacific Journal of Cancer Prevention
·
13
PDF
Apolipoprotein A1 and Transferrin as Biomarkers in Ovarian Cancer Diagnostics
2010
·
Ronalds Macuks
, Ieva Baidekalna
, et al.
·
Acta Chirurgica Latviensis
·
12
PDF
Subspecialty training in Europe: a report by the European Network of Young Gynaecological Oncologists
2020
·
Maximilian Lanner
, Tanja Nikolova
, et al.
·
International Journal of Gynecological Cancer
·
8
PDF
Prognostic factors in uterine adenosarcoma: subanalysis of the SARCUT study
2024
·
Rosanna Mancari
, Yildirim Yusuf
, et al.
·
Frontiers in Oncology
·
7
Influence of Clinical and Surgical Factors on Uterine Carcinosarcoma Survival
2023
·
Myriam Gracia
, Yusuf Yildirim
, et al.
·
Cancers
·
7
PDF
Comparison of different ovarian cancer detection algorithms.
2011
·
R Macuks
, I Baidekalna
, et al.
·
PubMed
·
6
Impact of perioperative characteristics on the recurrence risk and survival of patients with uterine leiomyosarcoma
2023
·
Myriam Gracia
, Yusuf Yildirim
, et al.
·
International Journal of Gynecology & Obstetrics
·
5
PDF
Prognostic factors for recurrence and survival in uncommon variants of vulvar cancer
2020
·
Ignacio Zapardiel
, Myriam Gracia
, et al.
·
Archives of Gynecology and Obstetrics
·
5
The influence of adjuvant radiotherapy on ovarian function,menopausal symptoms and quality of sexual life in cervicalcancer patients
2013
·
Natālija Bērza
, Jurgis Vitols
, et al.
·
International journal of collaborative research on internal medicine & public health
·
5
Impact of Hospital Case Volume on Uterine Sarcoma Prognosis: SARCUT Study Subanalysis
2023
·
Mikel Gorostidi
, Yusuf Yildirim
, et al.
·
Annals of Surgical Oncology
·
4
Prognostic factors in undifferentiated uterine sarcoma: a subanalysis of the SARCUT study
2023
·
Ronalds Macuks
, Yusuf Yildirim
, et al.
·
Archives of Gynecology and Obstetrics
·
4
PDF
Lymph node dissection in uterine leiomyosarcomas: A matched-pair study
2023
·
Pluvio J. Coronado
, Maria Alonso-Espias
, et al.
·
Gynecologic Oncology
·
4
Diagnostic test for ovarian cancer composed of ovarian cancer symptom index, menopausal status and ovarian cancer antigen CA125.
2011
·
R Macuks
, I Baidekalna
, et al.
·
PubMed
·
4
ASO Visual Abstract: Impact of Hospital Case Volume on Uterine Sarcoma Prognosis: SARCUT Study Subanalysis
2023
·
Mikel Gorostidi
, Yusuf Yildirim
, et al.
·
Annals of Surgical Oncology
·
3
Analysis of invasive cervical cancer cases in Latvia
2016
·
Anna Kornete
, Elizabete Pumpure
, et al.
·
International Journal of Reproduction Contraception Obstetrics and Gynecology
·
2
PDF
Management and prognosis of uterine sarcoma in elderly
2024
·
Mikel Gorostidi
, Violeta Romero
, et al.
·
Gynecology and Pelvic Medicine
·
1
Show more works
View as search
Works count:
39
Citation count:
369
H-index:
11
I10-index:
11
Year
Topic
Type